CLINICAL TRIALS PROFILE FOR DALIRESP
✉ Email this page to a colleague
All Clinical Trials for Daliresp
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01433666 ↗ | Roflumilast and Cognition | Completed | ZonMw: The Netherlands Organisation for Health Research and Development | Phase 2 | 2011-09-01 | The aim of the current project is to validate PDE4 inhibitors as a target for cognition enhancers (proof-of-concept) using a translational behaviour-EEG approach. The project will demonstrate whether memory, but also attention, information processing or executive function improves with the PDE4 inhibitor roflumilast in healthy humans. |
NCT01433666 ↗ | Roflumilast and Cognition | Completed | Maastricht University Medical Center | Phase 2 | 2011-09-01 | The aim of the current project is to validate PDE4 inhibitors as a target for cognition enhancers (proof-of-concept) using a translational behaviour-EEG approach. The project will demonstrate whether memory, but also attention, information processing or executive function improves with the PDE4 inhibitor roflumilast in healthy humans. |
NCT01443845 ↗ | Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) | Completed | AstraZeneca | Phase 4 | 2011-09-30 | To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination (FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very severe COPD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Daliresp
Condition Name
Clinical Trial Locations for Daliresp
Trials by Country
Clinical Trial Progress for Daliresp
Clinical Trial Phase
Clinical Trial Sponsors for Daliresp
Sponsor Name